C-Z5VJOncolife Therapeutics
stem cell biology, molecular therapies, cancer
modulating
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-Z5VJ
C-Z5VJC-Z5VJstem cell biology, molecular therapies, cancer
0-100 chain-logic scale · 15 dimensions · scored on public evidence
OncoLife Therapeutics states that cancer therapies should not be harmful or toxic to patients and that better understanding of human stem cell and cell biology can uncover molecular therapies that safely and effectively treat cancer, advancing medical innovation for global human benefit while improving healthspan and lifespan.
SourceOncoLife Therapeutics states that cancer therapies should not be harmful or toxic to patients, and that deeper understanding of human stem cell and cell biology will reveal molecular therapies that can safely and effectively treat cancer while advancing medical innovation for global human benefit. The company also says that aging compromises stem cell activity through both pre-programmed cellular processes and behavioral exposures such as stress, diet, and toxins, and that identifying the molecular mechanisms driving oncogenic change can enable intervention when stem cell activity becomes poorly regulated in cancer, ultimately increasing healthspan and lifespan.
SourceOncoLife Therapeutics states that improving metabolic and stem cell activity is central to achieving healthy ageing and eliminating cancer. The company says that deeper understanding of cell biology and metabolism will enable molecular therapies and interventions that extend healthspan and longevity, and it specifically believes that altering metabolism can increase healthspan while cancer treatments do not need to be toxic to patients.
SourceOncoLife Therapeutics states that deeper understanding of cell biology, metabolism, and stem cell activity can lead to molecular therapies that improve healthspan and longevity while also enabling cancer treatments that are not toxic to patients. The company argues that ageing and cancer both involve dysregulation of metabolism and stem cell activity, driven by programmed cellular processes over time as well as behavioral exposures such as stress, poor diet, and sedentary lifestyles.
Source